Documents & Downloads

Nagrestipen

Anticancer Agent

Nagrestipen is a variant of human macrophage inflammatory protein-1 alpha (MIP-1α) with demonstrated antitumor activity. This reagent is utilized in therapeutic trials to enhance the understanding of cancer biology, including tumor development, metastasis, and responses to radiation therapy. Its role in immunomodulation makes it a valuable tool for researching cancer treatment strategies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	166089-33-4
Applications	Anticancer Agent
Formula	C₃₃₈H₅₁₆N₈₈O₁₀₈S₄
Molecular Weight	7668.48

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.